Bioprocess Technology Market Report: Unlocking Growth Potential and Addressing Challenges
United States of America – July 30, 2025 – The Insight Partners is proud to announce its newest market report, “Bioprocess Technology Market Forecast to 2028 – Global Analysis – by Type, Modality, End User, and Geography”. The report provides a holistic view of the Bioprocess Technology Market and describes the current scenario as well as growth estimates of the market during the forecast period.

Overview of Bioprocess Technology Market

Bioprocess technology, a core area in biotechnology, integrates biological materials like cells or enzymes with physical or chemical processes to produce therapeutics, chemicals, and more. This market has witnessed rapid developments driven by growing chronic diseases, pharmaceutical innovations, and the rise of cell and gene therapies. Innovations such as Automated Real‐Time Flow Cytometry (ART-FCM), and an industry shift toward single-use systems, are dramatically transforming the space.

Key Findings and Insights

Market Size and Growth

• Historical Data: The Bioprocess Technology Market was valued at US$ 30,897.49 million in 2022.
• Forecast: It is projected to reach US$ 77,090.05 million by 2028, growing at a CAGR of 16.8% from 2023 to 2028.

Key Factors Driving Growth

• Increasing RD expenditures by pharmaceutical companies to develop novel drug compounds.
• Expiry of major drug patents, pushing companies to invest in biologics and bioprocessing methods.
• Emergence of biologics and gene therapies to treat rare diseases.
• Rapid adoption of single-use technologies to reduce contamination risks and streamline production.

Market Segmentation

By Type

• Cell Culture Media Bioprocess (Largest share in 2022)
• Chromatography Bioprocess (Fastest growing segment during 2023–2028)
• Consumables Accessories
• Others

By Modality

• Single Use (Largest market share in 2022)
• Multiple Use (Expected to grow at a higher CAGR)

By End User

• Biopharmaceutical Companies (Dominant segment in 2022)
• Academic Medical Institutions (Expected highest CAGR)
• Research Laboratories
• Others

Spotting Emerging Trends

Technological Advancements

The launch of BIOSTAT STR Generation 3 by Sartorius and collaboration between Merck and Agilent Technologies for Process Analytical Technologies (PAT) highlight the technological wave sweeping the bioprocess market. Bioprocessing 4.0 is becoming a reality, improving efficiency, reproducibility, and scalability.

Changing Consumer Preferences

With increasing health awareness, consumers are demanding more targeted, effective, and personalized therapies. This is fueling demand for advanced biologics and driving the adoption of modular, scalable bioprocess solutions.

Regulatory Changes

FDA approvals for gene therapies are increasing, with 10–20 new approvals annually. For instance, Bluebird Bio's Zynteglo was approved in 2022 for cerebral adrenoleukodystrophy (CALD), reflecting regulatory support for novel biotechnologies.

Growth Opportunities

• Asia Pacific is poised to register the highest CAGR, driven by biomanufacturing expansion in countries like China and India.
• China, in particular, accounts for ~25% of the country’s bioproduction capacity and is seeing strong investments in CDMOs and gene therapy development.
• Growing applications of single-use bioreactors, chromatography technologies, and real-time analytics are unlocking scalable, clean, and cost-efficient bioproduction methods.
• Academic institutions are also emerging as key contributors to innovation, offering significant growth potential.

Conclusion

“Bioprocess Technology Market – Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023–2028” provides much-needed insight for companies looking to establish or expand operations in this sector. With in-depth analysis of competitive dynamics, regional trends, emerging technologies, and key growth drivers, this report offers a strategic roadmap for stakeholders.